At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 253 enrolled
Drug / intervention
A-101drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Safety and Effectiveness of A-101(Hydrogen Peroxide) Topical Solution in Subjects With Seborrheic Keratosis Lesions on the Trunk, Extremities, and Face
In Brief
A Phase 2 clinical trial evaluating A-101 for Seborrheic Keratosis. Completed, enrolled 253 participants across 9 sites.
Detailed Summary
The primary objective of this study is to evaluate the safety and effectiveness of 2 concentrations of A-101 compared to Vehicle for the treatment of 4 seborrheic keratosis (SK) Target Lesions on the trunk, extremities and face.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSeborrheic Keratosis
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedMay 2017
Enrollment StartMay 2017
Primary CompletionFeb 2018
Study CompletionApr 2018
TodayJul 2026
First PostedMay 11, 2017
Enrollment StartMay 17, 2017
Primary CompletionFeb 28, 2018
Study CompletionApr 3, 2018
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 9.1 years ago
Interventions
A-101drug
Topical Solution